US Oncology Research Launches Innovative Clinical Trial Focused On Preventing Chemotherapy-Induced Hair Loss

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

THE WOODLANDS, Texas--(BUSINESS WIRE)--Hair loss from chemotherapy can be one of the most distressing and troublesome side effects cancer patients face, often impacting their body image, sexuality and overall well-being. Patients who lose their hair also lose their privacy as a cancer patient, as hair loss is commonly associated with cancer treatment. Now, there may be a way to stop or greatly reduce the hair loss that can occur with certain chemotherapy treatments. US Oncology Research—one of the largest community-based cancer research programs in the nation—and Baylor College of Medicine have recently launched a clinical trial to study a scalp cooling system designed to prevent chemotherapy-induced hair loss (alopecia). To date, 15 patients have been enrolled, and the study is now available at three US Oncology Research sites (listed below).

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC